img

Global DPT Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global DPT Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humansdiphtheria, pertussis (whooping cough), and tetanus.
DPT Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global DPT Vaccines market is projected to reach US$ 6619.4 million in 2034, increasing from US$ 5187.9 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Demand from 12 Months Below and 12 Months Above are the major drivers for the industry.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global DPT Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Age and Regions Listed in the Report



By Company


Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the DPT Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of DPT Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the DPT Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of DPT Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Age, Volume and Revenue analysis of Each Age in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, DPT Vaccines introduction, etc. DPT Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of DPT Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 DPT Vaccines Market Overview
1.1 DPT Vaccines Product Overview
1.2 DPT Vaccines Market Segment by Type
1.2.1 DTaP
1.2.2 Tdap
1.2.3 DTwP
1.3 Global DPT Vaccines Market Size by Type
1.3.1 Global DPT Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global DPT Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global DPT Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America DPT Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe DPT Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific DPT Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America DPT Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa DPT Vaccines Sales Breakdown by Type (2018-2024)
2 Global DPT Vaccines Market Competition by Company
2.1 Global Top Players by DPT Vaccines Sales (2018-2024)
2.2 Global Top Players by DPT Vaccines Revenue (2018-2024)
2.3 Global Top Players by DPT Vaccines Price (2018-2024)
2.4 Global Top Manufacturers DPT Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 DPT Vaccines Market Competitive Situation and Trends
2.5.1 DPT Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by DPT Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DPT Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into DPT Vaccines Market
2.8 Key Manufacturers DPT Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 DPT Vaccines Status and Outlook by Region
3.1 Global DPT Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global DPT Vaccines Historic Market Size by Region
3.2.1 Global DPT Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global DPT Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global DPT Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global DPT Vaccines Forecasted Market Size by Region
3.3.1 Global DPT Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global DPT Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global DPT Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global DPT Vaccines by Age
4.1 DPT Vaccines Market Segment by Age
4.1.1 12 Months Below
4.1.2 12 Months Above
4.2 Global DPT Vaccines Market Size by Age
4.2.1 Global DPT Vaccines Market Size Overview by Age (2018-2034)
4.2.2 Global DPT Vaccines Historic Market Size Review by Age (2018-2024)
4.2.3 Global DPT Vaccines Forecasted Market Size by Age (2024-2034)
4.3 Key Regions Market Size Segment by Age
4.3.1 North America DPT Vaccines Sales Breakdown by Age (2018-2024)
4.3.2 Europe DPT Vaccines Sales Breakdown by Age (2018-2024)
4.3.3 Asia-Pacific DPT Vaccines Sales Breakdown by Age (2018-2024)
4.3.4 Latin America DPT Vaccines Sales Breakdown by Age (2018-2024)
4.3.5 Middle East and Africa DPT Vaccines Sales Breakdown by Age (2018-2024)
5 North America DPT Vaccines by Country
5.1 North America DPT Vaccines Historic Market Size by Country
5.1.1 North America DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America DPT Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America DPT Vaccines Sales in Value by Country (2018-2024)
5.2 North America DPT Vaccines Forecasted Market Size by Country
5.2.1 North America DPT Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America DPT Vaccines Sales in Value by Country (2024-2034)
6 Europe DPT Vaccines by Country
6.1 Europe DPT Vaccines Historic Market Size by Country
6.1.1 Europe DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe DPT Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe DPT Vaccines Sales in Value by Country (2018-2024)
6.2 Europe DPT Vaccines Forecasted Market Size by Country
6.2.1 Europe DPT Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe DPT Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific DPT Vaccines by Region
7.1 Asia-Pacific DPT Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific DPT Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific DPT Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific DPT Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific DPT Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific DPT Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific DPT Vaccines Sales in Value by Region (2024-2034)
8 Latin America DPT Vaccines by Country
8.1 Latin America DPT Vaccines Historic Market Size by Country
8.1.1 Latin America DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America DPT Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America DPT Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America DPT Vaccines Forecasted Market Size by Country
8.2.1 Latin America DPT Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America DPT Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa DPT Vaccines by Country
9.1 Middle East and Africa DPT Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa DPT Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa DPT Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa DPT Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa DPT Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa DPT Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa DPT Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Pasteur DPT Vaccines Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK DPT Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Mitsubishi Tanabe Pharma
10.3.1 Mitsubishi Tanabe Pharma Company Information
10.3.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Products Offered
10.3.5 Mitsubishi Tanabe Pharma Recent Development
10.4 KM Biologics
10.4.1 KM Biologics Company Information
10.4.2 KM Biologics Introduction and Business Overview
10.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 KM Biologics DPT Vaccines Products Offered
10.4.5 KM Biologics Recent Development
10.5 Wuhan Institute of Biological Products
10.5.1 Wuhan Institute of Biological Products Company Information
10.5.2 Wuhan Institute of Biological Products Introduction and Business Overview
10.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Wuhan Institute of Biological Products DPT Vaccines Products Offered
10.5.5 Wuhan Institute of Biological Products Recent Development
10.6 Walvax Biotechnology
10.6.1 Walvax Biotechnology Company Information
10.6.2 Walvax Biotechnology Introduction and Business Overview
10.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Walvax Biotechnology DPT Vaccines Products Offered
10.6.5 Walvax Biotechnology Recent Development
10.7 Chengdu Institute of Biological Products
10.7.1 Chengdu Institute of Biological Products Company Information
10.7.2 Chengdu Institute of Biological Products Introduction and Business Overview
10.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Chengdu Institute of Biological Products DPT Vaccines Products Offered
10.7.5 Chengdu Institute of Biological Products Recent Development
10.8 Minhai Biotechnology
10.8.1 Minhai Biotechnology Company Information
10.8.2 Minhai Biotechnology Introduction and Business Overview
10.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Minhai Biotechnology DPT Vaccines Products Offered
10.8.5 Minhai Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 DPT Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 DPT Vaccines Industrial Chain Analysis
11.4 DPT Vaccines Market Dynamics
11.4.1 DPT Vaccines Industry Trends
11.4.2 DPT Vaccines Market Drivers
11.4.3 DPT Vaccines Market Challenges
11.4.4 DPT Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 DPT Vaccines Distributors
12.3 DPT Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of DTaP
Table 2. Major Company of Tdap
Table 3. Major Company of DTwP
Table 4. Global DPT Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global DPT Vaccines Sales by Type (2018-2024) & (M Doses)
Table 6. Global DPT Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 7. Global DPT Vaccines Sales by Type (2018-2024) & (US& Million)
Table 8. Global DPT Vaccines Market Share in Value by Type (2018-2024)
Table 9. Global DPT Vaccines Price by Type (2018-2024) & (US$/Dose)
Table 10. Global DPT Vaccines Sales by Type (2024-2034) & (M Doses)
Table 11. Global DPT Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global DPT Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global DPT Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global DPT Vaccines Price by Type (2024-2034) & (US$/Dose)
Table 15. North America DPT Vaccines Sales by Type (2018-2024) & (M Doses)
Table 16. North America DPT Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe DPT Vaccines Sales (M Doses) by Type (2018-2024)
Table 18. Europe DPT Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific DPT Vaccines Sales (M Doses) by Type (2018-2024)
Table 20. Asia-Pacific DPT Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America DPT Vaccines Sales (M Doses) by Type (2018-2024)
Table 22. Latin America DPT Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa DPT Vaccines Sales (M Doses) by Type (2018-2024)
Table 24. Middle East and Africa DPT Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Global DPT Vaccines Sales by Company (2018-2024) & (M Doses)
Table 26. Global DPT Vaccines Sales Share by Company (2018-2024)
Table 27. Global DPT Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global DPT Vaccines Revenue Share by Company (2018-2024)
Table 29. Global Market DPT Vaccines Price by Company (2018-2024) & (US$/Dose)
Table 30. Global DPT Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global DPT Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DPT Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into DPT Vaccines Market
Table 34. Key Manufacturers DPT Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global DPT Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global DPT Vaccines Sales by Region (2018-2024) & (M Doses)
Table 38. Global DPT Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 39. Global DPT Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 40. Global DPT Vaccines Sales Market Share in Value by Region (2018-2024)
Table 41. Global DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 42. Global DPT Vaccines Sales by Region (2024-2034) & (M Doses)
Table 43. Global DPT Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global DPT Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global DPT Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2034)
Table 47. Global DPT Vaccines Sales by Age: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global DPT Vaccines Sales by Age (2018-2024) & (M Doses)
Table 49. Global DPT Vaccines Sales Market Share in Volume by Age (2018-2024)
Table 50. Global DPT Vaccines Sales by Age (2018-2024) & (US$ Million)
Table 51. Global DPT Vaccines Sales Market Share in Value by Age (2018-2024)
Table 52. Global DPT Vaccines Price by Age (2018-2024) & (US$/Dose)
Table 53. Global DPT Vaccines Sales by Age (2024-2034) & (M Doses)
Table 54. Global DPT Vaccines Sales Market Share in Volume by Age (2024-2034)
Table 55. Global DPT Vaccines Sales by Age (2024-2034) & (US$ Million)
Table 56. Global DPT Vaccines Sales Market Share in Value by Age (2024-2034)
Table 57. Global DPT Vaccines Price by Age (2024-2034) & (US$/Dose)
Table 58. North America DPT Vaccines Sales by Age (2018-2024) (M Doses)
Table 59. North America DPT Vaccines Sales by Age (2018-2024) & (US$ Million)
Table 60. Europe DPT Vaccines Sales by Age (2018-2024) (M Doses)
Table 61. Europe DPT Vaccines Sales by Age (2018-2024) & (US$ Million)
Table 62. Asia-Pacific DPT Vaccines Sales by Age (2018-2024) (M Doses)
Table 63. Asia-Pacific DPT Vaccines Sales by Age (2018-2024) & (US$ Million)
Table 64. Latin America DPT Vaccines Sales by Age (2018-2024) (M Doses)
Table 65. Latin America DPT Vaccines Sales by Age (2018-2024) & (US$ Million)
Table 66. Middle East and Africa DPT Vaccines Sales by Age (2018-2024) (M Doses)
Table 67. Middle East and Africa DPT Vaccines Sales by Age (2018-2024) & (US$ Million)
Table 68. North America DPT Vaccines Sales by Country (2018-2024) & (M Doses)
Table 69. North America DPT Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 70. North America DPT Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 71. North America DPT Vaccines Sales Market Share in Value by Country (2018-2024)
Table 72. North America DPT Vaccines Sales by Country (2024-2034) & (M Doses)
Table 73. North America DPT Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America DPT Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America DPT Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe DPT Vaccines Sales by Country (2018-2024) & (M Doses)
Table 77. Europe DPT Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe DPT Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe DPT Vaccines Sales Market Share in Value by Country (2018-2024)
Table 80. Europe DPT Vaccines Sales by Country (2024-2034) & (M Doses)
Table 81. Europe DPT Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe DPT Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe DPT Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific DPT Vaccines Sales by Region (2018-2024) & (M Doses)
Table 85. Asia-Pacific DPT Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific DPT Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific DPT Vaccines Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific DPT Vaccines Sales by Region (2024-2034) & (M Doses)
Table 89. Asia-Pacific DPT Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific DPT Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific DPT Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America DPT Vaccines Sales by Country (2018-2024) & (M Doses)
Table 93. Latin America DPT Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America DPT Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America DPT Vaccines Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America DPT Vaccines Sales by Country (2024-2034) & (M Doses)
Table 97. Latin America DPT Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America DPT Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America DPT Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa DPT Vaccines Sales by Country (2018-2024) & (M Doses)
Table 101. Middle East and Africa DPT Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa DPT Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa DPT Vaccines Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa DPT Vaccines Sales by Country (2024-2034) & (M Doses)
Table 105. Middle East and Africa DPT Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa DPT Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa DPT Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Sanofi Pasteur Company Information
Table 109. Sanofi Pasteur Introduction and Business Overview
Table 110. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 111. Sanofi Pasteur DPT Vaccines Product
Table 112. Sanofi Pasteur Recent Development
Table 113. GSK Company Information
Table 114. GSK Introduction and Business Overview
Table 115. GSK DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 116. GSK DPT Vaccines Product
Table 117. GSK Recent Development
Table 118. Mitsubishi Tanabe Pharma Company Information
Table 119. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 120. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 121. Mitsubishi Tanabe Pharma DPT Vaccines Product
Table 122. Mitsubishi Tanabe Pharma Recent Development
Table 123. KM Biologics Company Information
Table 124. KM Biologics Introduction and Business Overview
Table 125. KM Biologics DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 126. KM Biologics DPT Vaccines Product
Table 127. KM Biologics Recent Development
Table 128. Wuhan Institute of Biological Products Company Information
Table 129. Wuhan Institute of Biological Products Introduction and Business Overview
Table 130. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 131. Wuhan Institute of Biological Products DPT Vaccines Product
Table 132. Wuhan Institute of Biological Products Recent Development
Table 133. Walvax Biotechnology Company Information
Table 134. Walvax Biotechnology Introduction and Business Overview
Table 135. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 136. Walvax Biotechnology DPT Vaccines Product
Table 137. Walvax Biotechnology Recent Development
Table 138. Chengdu Institute of Biological Products Company Information
Table 139. Chengdu Institute of Biological Products Introduction and Business Overview
Table 140. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 141. Chengdu Institute of Biological Products DPT Vaccines Product
Table 142. Chengdu Institute of Biological Products Recent Development
Table 143. Minhai Biotechnology Company Information
Table 144. Minhai Biotechnology Introduction and Business Overview
Table 145. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 146. Minhai Biotechnology DPT Vaccines Product
Table 147. Minhai Biotechnology Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. DPT Vaccines Market Trends
Table 151. DPT Vaccines Market Drivers
Table 152. DPT Vaccines Market Challenges
Table 153. DPT Vaccines Market Restraints
Table 154. DPT Vaccines Distributors List
Table 155. DPT Vaccines Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. DPT Vaccines Product Picture
Figure 2. Global DPT Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global DPT Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global DPT Vaccines Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of DTaP
Figure 6. Global DTaP Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Tdap
Figure 8. Global Tdap Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Product Picture of DTwP
Figure 10. Global DTwP Sales YoY Growth (2018-2034) & (M Doses)
Figure 11. Global DPT Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global DPT Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America DPT Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America DPT Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe DPT Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe DPT Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific DPT Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific DPT Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America DPT Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America DPT Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa DPT Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa DPT Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by DPT Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by DPT Vaccines Revenue in 2022
Figure 25. DPT Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of 12 Months Below
Figure 27. Global 12 Months Below Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Product Picture of 12 Months Above
Figure 29. Global 12 Months Above Sales YoY Growth (2018-2034) & (M Doses)
Figure 30. Global DPT Vaccines Sales by Age (2018-2034) & (US$ Million)
Figure 31. Global DPT Vaccines Sales Market Share by Age in 2022 & 2034
Figure 32. North America DPT Vaccines Sales Market Share in Volume by Age in 2022
Figure 33. North America DPT Vaccines Sales Market Share in Value by Age in 2022
Figure 34. Europe DPT Vaccines Sales Market Share in Volume by Age in 2022
Figure 35. Europe DPT Vaccines Sales Market Share in Value by Age in 2022
Figure 36. Asia-Pacific DPT Vaccines Sales Market Share in Volume by Age in 2022
Figure 37. Asia-Pacific DPT Vaccines Sales Market Share in Value by Age in 2022
Figure 38. Latin America DPT Vaccines Sales Market Share in Volume by Age in 2022
Figure 39. Latin America DPT Vaccines Sales Market Share in Value by Age in 2022
Figure 40. Middle East and Africa DPT Vaccines Sales Market Share in Value by Age in 2022
Figure 41. Key Raw Materials Price
Figure 42. DPT Vaccines Manufacturing Cost Structure
Figure 43. DPT Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed